Detalhe da pesquisa
1.
Mucus-degrading Bacteroides link carbapenems to aggravated graft-versus-host disease.
Cell
; 185(20): 3705-3719.e14, 2022 09 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36179667
2.
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.
N Engl J Med
; 388(25): 2338-2348, 2023 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37342922
3.
A phase 2 study of interleukin-22 and systemic corticosteroids as initial treatment for acute GVHD of the lower GI tract.
Blood
; 141(12): 1389-1401, 2023 03 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36399701
4.
Effective treatment of low-risk acute GVHD with itacitinib monotherapy.
Blood
; 141(5): 481-489, 2023 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36095841
5.
Blinatumomab maintenance after allogeneic hematopoietic cell transplantation for B-lineage acute lymphoblastic leukemia.
Blood
; 139(12): 1908-1919, 2022 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34914826
6.
Mycophenolate mofetil is associated with inferior overall survival in cytomegalovirus seropositive patients with acute myeloid leukemia undergoing hematopoietic cell transplantation.
Haematologica
; 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38426274
7.
Patient-reported treatment response in chronic graft-versus-host disease.
Haematologica
; 109(1): 143-150, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37226713
8.
Eltrombopag improves platelet engraftment after haploidentical bone marrow transplantation: Results of a Phase II study.
Am J Hematol
; 99(4): 562-569, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38314663
9.
Characteristics and clinical outcomes of patients with acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2).
Haematologica
; 108(9): 2331-2342, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36951163
10.
Younger haploidentical donor versus older matched unrelated donor for patients with AML/MDS.
Am J Hematol
; 98(5): 712-719, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36734029
11.
Evolving trends and outcomes in older patients with acute myeloid leukemia including allogeneic stem cell transplantation.
Am J Hematol
; 98(9): 1383-1393, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37334870
12.
Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation?
Blood
; 135(6): 449-452, 2020 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31826244
13.
Randomized multicenter trial of sirolimus vs prednisone as initial therapy for standard-risk acute GVHD: the BMT CTN 1501 trial.
Blood
; 135(2): 97-107, 2020 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31738834
14.
Improved outcomes of high-risk relapsed Hodgkin lymphoma patients after high-dose chemotherapy: a 15-year analysis.
Haematologica
; 107(4): 899-908, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33951890
15.
Fractionated busulfan myeloablative conditioning improves survival in older patients with acute myeloid leukemia and myelodysplastic syndrome.
Cancer
; 127(10): 1598-1605, 2021 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33471943
16.
Cytogenetics and Blast Count Determine Transplant Outcomes in Patients with Active Acute Myeloid Leukemia.
Acta Haematol
; 144(1): 74-81, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32604096
17.
Optimizing the Conditioning Regimen for Hematopoietic Cell Transplant in Myelofibrosis: Long-Term Results of a Prospective Phase II Clinical Trial.
Biol Blood Marrow Transplant
; 26(8): 1439-1445, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32438043
18.
Novel Disease Risk Model for Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 26(1): 197-203, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31518645
19.
Outcome of Multiple Myeloma with Chromosome 1q Gain and 1p Deletion after Autologous Hematopoietic Stem Cell Transplantation: Propensity Score Matched Analysis.
Biol Blood Marrow Transplant
; 26(4): 665-671, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31881283
20.
Significance of minimal residual disease monitoring by real-time quantitative polymerase chain reaction in core binding factor acute myeloid leukemia for transplantation outcomes.
Cancer
; 126(10): 2183-2192, 2020 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32101640